Equities

IVF Hartmann Holding AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

IVF Hartmann Holding AG

Actions
  • Price (CHF)147.00
  • Today's Change2.00 / 1.38%
  • Shares traded44.00
  • 1 Year change+0.68%
  • Beta0.1484
Data delayed at least 15 minutes, as of Feb 16 2026 11:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.

  • Revenue in CHF (TTM)159.45m
  • Net income in CHF19.02m
  • Incorporated1883
  • Employees309.00
  • Location
    IVF Hartmann Holding AGVictor von Bruns-Strasse 28NEUHAUSEN AM RHEINFALL 8212SwitzerlandCHE
  • Phone+41 526743111
  • Fax+41 526727441
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Affluent Medical SAS3.75m-13.43m194.31m76.00--6.71--51.79-0.3759-0.37590.10510.53650.0709--0.954159,681.16-25.40-23.76-32.61-27.591.34-226.93-358.01-1,815.40---924.300.5030------5.84------
Prim SA219.08m13.26m201.01m954.0014.111.668.650.91750.91760.917614.137.801.171.974.17251,008.807.096.2710.408.5038.7737.706.055.851.20144.870.139963.107.689.08-13.83-0.536613.506.35
Tristel Plc48.68m6.96m210.89m265.0030.376.0721.324.330.13830.13830.96760.69151.041.935.81175,328.3014.859.6017.5711.0980.6280.9014.2911.042.96--0.1512120.7110.807.962.335.42-3.5918.10
Onward Medical NV1.01m-35.21m211.26m102.00--6.67--208.52-0.866-0.8660.02490.62090.0215--9.1110,901.96-74.86-55.03-92.84-61.1977.16---3,475.81-39,652.374.30-17.130.352--236.76--1.26--3.88--
Stratec SE234.06m14.26m220.65m1.42k15.471.017.020.94271.291.2921.1319.750.58251.325.65177,177.203.556.724.247.9629.0928.416.099.631.656.850.355237.35-4.733.764.242.35-7.49-6.51
Medistim ASA54.03m11.51m286.01m154.0024.788.4320.955.297.797.7936.5622.911.250.76799.674,341,637.0026.7221.9833.0927.1981.2178.6621.3020.322.03--0.048485.046.889.120.00878.1112.5316.89
CellaVision AB65.30m13.17m314.78m236.0023.904.1219.024.826.426.4231.8237.210.72012.026.80--14.5214.7116.2216.9668.5068.3820.1719.852.9725.880.028141.974.949.998.7811.3420.7629.67
COLTENE Holding AG240.71m14.31m328.66m1.18k22.963.6315.601.372.402.4040.2215.131.311.346.40204,684.507.8010.5914.2618.4366.1162.195.957.640.70437.620.360685.663.06-1.7971.310.4306-15.4510.76
IVF Hartmann Holding AG159.45m19.02m348.00m309.0018.312.3914.382.187.927.9266.3960.570.89643.287.88526,221.1010.697.9012.919.6855.7154.0611.939.133.79--0.004248.547.332.8534.0210.78-28.9419.92
Ion Beam Applications SA543.58m15.49m425.43m2.10k27.163.8015.840.78270.56770.567720.174.060.97562.733.28281,693.602.781.5012.034.6431.2134.392.852.150.62097.410.363170.816.7512.01201.573.997.6925.86
Revenio Group Oyj99.95m15.85m452.14m247.0028.444.3122.764.520.6540.6544.124.310.75153.057.26444,129.6011.9214.0014.2317.4070.9270.9515.8619.381.639.660.0969--5.9712.43-5.935.4222.19--
Lumibird SA196.75m9.77m476.93m1.07k48.802.6217.202.420.47750.47759.618.900.50770.95934.42202,198.502.522.513.113.1763.8961.894.974.901.643.160.45830.001.7513.34-20.08-8.3815.27--
medmix AG468.10m-5.80m481.12m2.67k--1.129.881.03-0.1696-0.169611.6010.390.47073.565.86174,403.90-0.49271.27-0.61991.5534.5235.24-1.052.651.101.870.4268140.79-0.55492.84-2,566.67--6.02--
RaySearch Laboratories AB (publ)115.65m19.60m491.28m458.0027.896.4511.014.256.656.6539.2528.740.65846.252.932,935,074.0011.165.2616.217.7792.4291.0116.949.701.6664.920.286152.3812.7715.5811.93--0.2213--
Advanced Medical Solutions Group plc230.83m9.56m499.28m1.50k52.051.8615.682.160.04170.04171.011.170.57582.095.57137,690.002.385.092.635.5252.1955.064.1411.151.553.880.242833.4740.6611.64-55.35-17.818.3610.90
Data as of Feb 16 2026. Currency figures normalised to IVF Hartmann Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

1.59%Per cent of shares held by top holders
HolderShares% Held
UBS Asset Management Switzerland AGas of 03 Feb 202619.64k0.82%
Principal Verm�gensverwaltung AGas of 31 Dec 20244.70k0.20%
Z�rcher Kantonalbank (Investment Management)as of 31 Dec 20254.06k0.17%
Deka Investment GmbHas of 30 Jun 20253.23k0.14%
Pictet Asset Management SAas of 31 Oct 20251.87k0.08%
BlackRock Asset Management Deutschland AGas of 05 Feb 20261.56k0.07%
Ante Asset Management AGas of 31 Dec 20251.45k0.06%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025688.000.03%
Swiss Life Asset Management AGas of 30 Sep 2025554.000.02%
DWS CH AGas of 31 Oct 2025466.000.02%
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.